Conversion therapy for advanced penile cancer with tislelizumab combined with chemotherapy: A case report and review of literature

Figure 1 Computed tomography images at different treatment periods. A: November 30, 2019: Computed tomography (CT) images before epidermal growth factor receptor monoclonal antibody therapy; B: February 25, 2020: CT images before chemotherapy but after epidermal growth factor receptor monoclonal antibody treatment; C: April 7, 2020: CT image of tumor lesions after the first round of chemotherapy alone; D: May 30, 2020: CT image for preoperative evaluation after the third round of immunotherapy combined with chemotherapy; E: April 09, 2021: CT images at the 10-mo follow-up after bilateral inguinal lymph node dissection.

Figure 2 The timeline of treatment and procedures. EGFR: Epidermal growth factor receptor.